Nasdaq Sage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq sage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Sage Today - Breaking & Trending Today

Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $28.00 by Analysts at JPMorgan Chase & Co.

Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $29.00 to $28.00 in a report published on Wednesday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Goldman Sachs Group , First Advisors Inc , Sage Therapeutics Inc , Needham Company , Jpmorgan Chase Co , China Universal Asset Management Co , Quest Partners , Sage Therapeutics , Free Report , Therapeutics Stock Down , Get Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , First Advisors , Sage Therapeutics Daily , Nasdaq Sage , Lower Price Target , Jpmorgan Chase Co ,

Royal Bank of Canada Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $15.00

Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target decreased by analysts at Royal Bank of Canada from $26.00 to $15.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective would suggest a potential […] ....

Sakhalinskaya Oblast , United States , Zurcher Kantonalbank Zurich Cantonalbank , Sage Therapeutics Inc , Morgan Stanley , Sage Therapeutics Company Profile , China Universal Asset Management Co , First Advisors Inc , Royal Bank , Quest Partners , Sage Therapeutics , Get Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , First Advisors , Sage Therapeutics Daily , Nasdaq Sage , Lower Price Target , Royal Bank Of Canada ,

Sage Therapeutics (NASDAQ:SAGE) PT Lowered to $18.00

Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price objective decreased by stock analysts at Truist Financial from $22.00 to $18.00 in a report released on Friday, Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Truist Financial’s target price indicates a potential upside of 31.48% from the stock’s […] ....

United States , Morgan Stanley , Sage Therapeutics Inc , China Universal Asset Management Co , Swiss National Bank , Needham Company , Sage Therapeutics , Get Free Report , Truist Financial , Retirement System , Universal Asset Management , National Bank , Sage Therapeutics Daily , Nasdaq Sage , Lower Price Target , Truist Financial Co ,

Sage Therapeutics (NASDAQ:SAGE) Upgraded at StockNews.com

StockNews.com upgraded shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Several other analysts also recently commented on SAGE. Truist Financial lowered their price objective on Sage Therapeutics from $22.00 to $18.00 and set a hold rating for the company […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Morgan Stanley , Needham Company , Sage Therapeutics Inc , Mirae Asset Global Investments Co , Sg Americas Securities , Harbor Capital Advisors Inc , Sage Therapeutics , Free Report , Get Free Report , Capital Advisors , Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments , Asset Global Investments , Sage Therapeutics Daily , Nasdaq Sage , Stocknews Com ,

Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $18.00 by Analysts at Truist Financial

Sage Therapeutics (NASDAQ:SAGE – Free Report) had its target price decreased by Truist Financial from $22.00 to $18.00 in a research report sent to investors on Friday, Benzinga reports. Truist Financial currently has a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also commented on SAGE. Canaccord Genuity Group decreased their price […] ....

New Zealand General , New Zealand , Vanguard Group Inc , Needham Company , Rafferty Asset Management , Wellington Management Group , Algert Global , Sage Therapeutics Company Profile , Sage Therapeutics Inc , Canaccord Genuity Group , Primecap Management Co , Jpmorgan Chase Co , Sage Therapeutics , Free Report , Truist Financial , Genuity Group , Get Free Report , Management Group , Asset Management , Primecap Management , Sage Therapeutics Daily , Nasdaq Sage , Lower Price Target , Truist Financial Co ,